Scholarlink

<p>The purpose of this study is to non-invasively image subtle blood–brain barrier (BBB) permeability changes in a state of chronic neuroinflammation using radiolabelled human serum albumin (HSA). Although biomarker-based methods for detecting BBB dysfunctions have been established, sensitive spatial and quantitative imaging of low-grade, chronic BBB permeability changes remains limited. This study seeks to establish radiolabelled albumin as a sensitive radiotracer for visualizing and quantifying BBB dysfunction during chronic neuroinflammation. This study evaluated the utility of radiolabeled serum albumin ([<sup>89</sup>Zr]Zr-DFO-HSA) for assessing BBB permeability using co-registered PET and MR imaging in a transgenic mouse model of neuroinflammation mediated by IKK/NF-κB activation. PET and MRI revealed significantly increased radiotracer accumulation in the cerebellum of neuroinflammatory mice, corroborated by <i>ex vivo</i> analyses. Quantitative PET data revealed elevated intracerebral radiotracer concentrations over 24&#xa0;h, even in the absence of morphological changes in histological evaluations. These findings emphasize the sensitivity of [<sup>89</sup>Zr]Zr-DFO-HSA in detecting early-stage BBB permeability changes prior to the onset of overt morphological damage or clinical symptoms. As a surrogate marker for macromolecular leakage, this non invasive imaging approach shows promise for advancing preclinical research into neuroinflammatory disorders and barrier dysfunctions.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Detection of inflammation-related blood–brain barrier dysfunction using PET and MR imaging: a pilot study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月10日

查看全文
  • Colmar F. Hilbrig,
  • Bernd Baumann,
  • Wolfgang Sievert,
  • Rebecca Halbgebauer,
  • Markus Huber-Lang,
  • Ambros J. Beer,
  • Volker Rasche,
  • Jessica Löffler

摘要

The purpose of this study is to non-invasively image subtle blood–brain barrier (BBB) permeability changes in a state of chronic neuroinflammation using radiolabelled human serum albumin (HSA). Although biomarker-based methods for detecting BBB dysfunctions have been established, sensitive spatial and quantitative imaging of low-grade, chronic BBB permeability changes remains limited. This study seeks to establish radiolabelled albumin as a sensitive radiotracer for visualizing and quantifying BBB dysfunction during chronic neuroinflammation. This study evaluated the utility of radiolabeled serum albumin ([89Zr]Zr-DFO-HSA) for assessing BBB permeability using co-registered PET and MR imaging in a transgenic mouse model of neuroinflammation mediated by IKK/NF-κB activation. PET and MRI revealed significantly increased radiotracer accumulation in the cerebellum of neuroinflammatory mice, corroborated by ex vivo analyses. Quantitative PET data revealed elevated intracerebral radiotracer concentrations over 24 h, even in the absence of morphological changes in histological evaluations. These findings emphasize the sensitivity of [89Zr]Zr-DFO-HSA in detecting early-stage BBB permeability changes prior to the onset of overt morphological damage or clinical symptoms. As a surrogate marker for macromolecular leakage, this non invasive imaging approach shows promise for advancing preclinical research into neuroinflammatory disorders and barrier dysfunctions.